BioMimetic Therapeutics Inc.
389-A Nichol Mill Lane
Franklin,
TN 37067
United States - Map
Phone: 615-844-1280
Fax: 615-844-1281
Web Site: http://www.biomimetics.com
| BioMimetic Therapeutics, Inc. develops and commercializes regenerative protein therapeutic-device combination products. Its products are primarily used for bone and tissue regeneration for the repair and healing of musculoskeletal injuries and conditions affecting bones, tendons, ligaments, and cartilage within orthopedic, spine, and sports injury applications. The companys lead orthopedic product candidate includes Augment Bone Graft, for treating bone defects and injuries. It also has pre-clinical products, which include Augment Injectable Bone Graft for closed non-surgical fracture treatment; TBD for spine fusion; and Augment C for cartilage repair and Augment LT for ligament and tendon repair. The company was formerly known as BioMimetic Pharmaceuticals, Inc. and changed its name to BioMimetic Therapeutics, Inc. in July 2005. BioMimetic Therapeutics, Inc. was founded in 1999 and is headquartered in Franklin, Tennessee. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. Samuel E. Lynch D.M.D., D.M.Sc., 49
Founder, Chief Exec. Officer, Pres |
$
583.00K |
$
118.00K | Mr. Lawrence E. Bullock , 53
Chief Financial Officer, Principal Accounting Officer and Corp. Sec. |
$
318.00K |
$
0 | Mr. Steven N. Hirsch , 57
Chief Operating Officer, Head of Corp. Communications and Exec. VP of Orthopedics |
$
403.00K |
$
0 | Mr. Earl M. Douglas Esq., 46
Gen. Counsel |
$
277.00K |
$
53.00K | Dr. Russ Pagano Ph.D, 43
VP of Regulatory and Clinical Affairs |
$
260.00K |
$
0 |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.22% Nasdaq 
Profile
